Back to Screener

Basic Materials

Novozymes A/S(NVZMY)

Live Price

Offline

$61.87

-1.64% today

1Y Change

-17.49%

Window

Jun 26, 2025 โ†’ Jun 18, 2026

Market Cap
$24.92B
Revenue Growth
+8.5%
EPS Growth
+22.7%
Dividend Yield
1.6%

Coverage: 246 bars ยท Jun 26, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Novozymes A/S (NVZMY) is a Basic Materials stock with a market cap of $24.92B and listed on OTC. The stock last traded around $61.87 and down 17.5% across the available one-year price window (Jun 26, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +8.5%, EPS growth of +22.7%, a dividend yield of 1.6%. What stands out right now is revenue +8.5%, EPS +22.7%, free cash flow +13.7% with operating margin 21.2% and ROIC 2.6%. The dividend is present but secondary, with a yield around 1.6%. Valuation already assumes a fairly strong business story at P/E 38.0 and price/sales 6.0. Stock Foundry combines NVZMY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Basic Materials peers on this page.

Benchmark Edge

NVZMY vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

NVZMY

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

NVZMY Max Drawdown

-26.99%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for NVZMY and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

Novozymes A/S (NVZMY)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$15.0B

-14.8% YoY

FY Net Income

$3.1B

-14.4% YoY

Free Cash Flow

$2.8B

+152.9% YoY

Revenue Growth

+8.5%

EPS Growth

+22.7%

Gross Margin

53.9%

Net Margin

14.0%

Income statement

EUR

Annual
Metric20252024202320222021
Revenue4.2B3.8B17.9B17.6B15.0B
Gross Profit2.2B1.8B9.7B9.6B8.6B
Operating Income883M659M4.0B4.6B4.0B
EBITDA1.4B8.1B5.5B6.1B5.4B
Net Income584M306M3.0B3.7B3.1B
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

EUR

Point-in-time
Metric20252024202320222021
Cash & Equivalents275M280M1.1B1.0B963M
Total Assets16.3B15.2B28.4B28.0B24.8B
Total Liabilities5.5B4.0B14.0B13.8B12.6B
Shareholder Equity10.9B11.2B14.0B13.8B11.8B
Total Debt22.4B1.8B7.7B411M482M
Net Debt22.2B1.5B6.6B-630M-481M

Cash flow positioning

Latest Full Year

Operating Cash Flow

4.1B

+1.4% YoY

Capital Expenditures

1.2B

+57.1% YoY

Free Cash Flow

2.8B

+152.9% YoY

Key ratios

  • Gross Margin

    53.9%

  • Operating Margin

    21.2%

  • Net Margin

    14.0%

  • ROE

    5.4%

  • Debt / Equity

    2.07x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.